Description

BSE announces listing of commercial paper worth Rs. 200 crores issued by Julius Baer Capital (India) Private Limited on private placement basis, effective December 12, 2025.

Summary

BSE has listed new commercial paper issued by Julius Baer Capital (India) Private Limited on private placement basis, effective December 12, 2025. The listing comprises two tranches totaling 4,000 units (Rs. 200 crores) with 91-day maturity, rated CRISIL A1+ and ICRA A1+. The instruments will trade in dematerialized form on the BSE Debt segment under ISIN INE824H14RO8.

Key Points

  • Total issuance: 4,000 units (3,000 + 1,000 units) of Rs. 5 lakhs each
  • Total value: Rs. 200 crores
  • Face value: Rs. 5,00,000 per unit
  • Issue price: Rs. 4,91,869.50 per unit
  • Scrip Code: 728983
  • Scrip ID: JBCIP13325
  • ISIN: INE824H14RO8 (further listing under same ISIN)
  • Credit rating: CRISIL A1+ and ICRA A1+
  • Market lot: 1 unit
  • Tick size: 1 paise
  • Issuing and paying agent: HDFC Bank Limited

Regulatory Changes

No regulatory changes introduced. This is a standard debt instrument listing notification.

Compliance Requirements

  • Trading members must trade these securities only in dematerialized form
  • Trading shall take place in standard denomination of Rs. 5 lakhs and multiples thereof
  • Securities will be traded under the specified ISIN number INE824H14RO8

Important Dates

  • Listing date: December 12, 2025
  • Date of allotment: December 12, 2025
  • Redemption date: March 13, 2026
  • Tenure: 91 days

Impact Assessment

Minimal market impact. This is a routine commercial paper listing in the debt segment on private placement basis. The instruments are short-term (91-day) money market securities with high credit ratings (A1+), indicating low credit risk. No impact on equity markets or broader trading operations. The listing provides additional short-term debt instruments for institutional investors and adds liquidity to the debt market segment.

Impact Justification

Routine debt instrument listing for commercial paper on private placement basis with no impact on equity markets or broader trading operations